Trial of Hypofractionated Post-Prostatectomy Radiation Therapy vs Conventional Post-Prostatectomy Radiation Therapy

Status: open

A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)

Treatment for Prostate Cancer

Contact Us Or call (251) 445-9834

Description

This randomized phase III trial studies how well hypofractionated radiation therapy works compared to conventional radiation therapy after surgery in treating patients with prostate cancer.

Sponsors

This trial is sponsored by NRG Oncology.

Providers Associated With This Trial

Principle Investigator

    Sub Investigators

    • Elesyia OutlawView Profile
      Elesyia D. Outlaw, M.D.Radiation OncologistDirector of Women's Radiotherapy Program; Program Director of Brachytherapy Program; Associate Professor of Interdisciplinary Clinical Oncology
    This link will open in a new tab or window.